The groundbreaking approach of the medication represents a significant development in the management of type 2 diabetes. Unlike existing medications, tirzepatide affects dual pathways – GLP-1 and the GIP hormone – https://tirzepatide-peptide460401.howeweb.com/42652936/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment